Six-month randomized clinical trial comparing intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma

被引：3
|
作者：
Fellenbaum, PS
机构：
来源：
AMERICAN JOURNAL OF OPHTHALMOLOGY | 2003年 / 136卷 / 02期
关键词：
D O I：
10.1016/S0002-9394(03)00247-2
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：392 / 392
页数：1
相关论文
共 50 条
  • [1] A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma
    Noecker, RS
    Dirks, MS
    Choplin, NT
    Bernstein, P
    Batoosingh, AL
    Whitcup, SM
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2003, 135 (01) : 55 - 63
  • [2] A six-month randomized clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma
    Robin, AL
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2003, 135 (06) : 921 - 922
  • [3] Randomized clinical trial comparing intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma - Author reply
    Noecker, RJ
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2003, 136 (01) : 217 - 218
  • [4] A six-month randomized clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma - Author reply
    Noecker, RS
    Dirks, MS
    Choplin, NT
    Bernstein, P
    Batoosingh, AL
    Whitcup, SM
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2003, 135 (06) : 922 - 923
  • [5] Intraocular pressure-lowering efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension
    Noecker, R.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2006, 90 (11) : 1336 - 1337
  • [6] Comparison of the Diurnal Intraocular Pressure-Lowering Efficacy of Bimatoprost 0.03%, Latanoprost 0.005% and Travoprost 0.004% in Patients with Glaucoma
    Ferreras, A.
    Pajarin, A. B.
    Pablo, L. E.
    Larrosa, J. M.
    Polo, V.
    PROCEEDINGS OF THE 7TH INTERNATIONAL SYMPOSIUM ON OCULAR PHARMACOLOGY AND THERAPEUTICS, 2008, : 119 - +
  • [7] Intraocular pressure-lowering efficacy and safety of bimatoprost 0.03% therapy for primary open-angle glaucoma and ocular hypertension patients in China
    Kaidi Wang
    Li Xu
    Zhilan Yuan
    Ke Yao
    Junmei Zhao
    Liang Xu
    Aiwu Fang
    Mingzhi Zhang
    Lingling Wu
    Jian Ji
    Jiamin Hou
    Qing Liu
    Xinghuai Sun
    BMC Ophthalmology, 14
  • [8] Late-day intraocular pressure-lowering efficacy and tolerability of travoprost 0.004% versus bimatoprost 0.01% in patients with open-angle glaucoma or ocular hypertension: a randomized trial
    DuBiner, Harvey B.
    Hubatsch, Douglas A.
    BMC OPHTHALMOLOGY, 2014, 14
  • [9] Intraocular pressure-lowering efficacy and safety of bimatoprost 0.03% therapy for primary open-angle glaucoma and ocular hypertension patients in China
    Wang, Kaidi
    Xu, Li
    Yuan, Zhilan
    Yao, Ke
    Zhao, Junmei
    Xu, Liang
    Fang, Aiwu
    Zhang, Mingzhi
    Wu, Lingling
    Ji, Jian
    Hou, Jiamin
    Liu, Qing
    Sun, Xinghuai
    BMC OPHTHALMOLOGY, 2014, 14
  • [10] A 3-month clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with normal-tension glaucoma
    Dirks, Monte S.
    Noecker, Robert J.
    Earl, Melissa
    Roh, Shiyoung
    Silverstein, Steven M.
    Williams, Robert D.
    ADVANCES IN THERAPY, 2006, 23 (03) : 385 - 394
12345